Results for "The Role of Distributors in the U.S. Specialty Pharmaceuticals Value Chain"
HDA Issues Policy Platform Addressing Drug Shortages
HDA and its pharmaceutical distributor members released a policy agenda to combat drug shortages, centering around three core themes: federal coordination, strategic investment and end-to-end stabilization of the generic drug supply chain.
Rx Supply Chain Progressing on EPCIS Adoption for DSCSA, Yet Challenges Still Remain
Updated survey data released today by the HDA Research Foundation indicate that healthcare supply chain partners remain in the formative stages of establishing the interoperable transaction data connections required to comply with the Drug Supply Chain Security Act (DSCSA) by November 27, 2023. However, some progress has been made since a previous survey conducted last spring.